Deciding Between Hormone Therapies in Patients With ER+/PR+ Tumors

August 12, 2014
Ragene Rivera, MD

Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses how she decides between hormone therapies in patients with ER+/PR+ tumors.

Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses how she decides between hormone therapies in patients with ER+/PR+ tumors.

This segment is a part of our Case-Based Peer Perspectives.View the case details > >